Cargando…
Insight into the Pathology of a COL1A1 Signal Peptide Heterozygous Mutation Leading to Severe Osteogenesis Imperfecta
Osteogenesis imperfecta or “brittle bone disease” is a congenital disorder of connective tissue causing the bone to break easily. Around 85–90% of cases are due to autosomal dominant mutations in the genes encoding type I collagen, the major organic component of bone. Genotype–phenotype correlations...
Autores principales: | Lindert, U., Gnoli, M., Maioli, M., Bedeschi, M.F., Sangiorgi, L., Rohrbach, M., Giunta, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818590/ https://www.ncbi.nlm.nih.gov/pubmed/29101475 http://dx.doi.org/10.1007/s00223-017-0359-z |
Ejemplares similares
-
Urinary pyridinoline cross-links as biomarkers of osteogenesis imperfecta
por: Lindert, Uschi, et al.
Publicado: (2015) -
Genotype–phenotype correlation study in 364 osteogenesis imperfecta Italian patients
por: Maioli, Margherita, et al.
Publicado: (2019) -
Identification of a novel heterozygous mutation in exon 50 of the COL1A1 gene causing osteogenesis imperfecta
por: Aftab, S A S, et al.
Publicado: (2013) -
Vitamin D and Bone fragility in Individuals with Osteogenesis Imperfecta: A Scoping Review
por: Gnoli, Maria, et al.
Publicado: (2023) -
COL1-Related Disorders: Case Report and Review of Overlapping Syndromes
por: Gnoli, Maria, et al.
Publicado: (2021)